Chang SM - Search Results

1

Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.

Appin CL, Hong C, Suwala AK, Hilz S, Mathur R, Solomon DA, Smirnov IV, Stevers NO, Shai A, Wang A, Berger MS, Chang SM, Phillips JJ, Costello JF. Appin CL, et al. Among authors: chang sm. Neuro Oncol. 2024 Apr 5;26(4):640-652. doi: 10.1093/neuonc/noad231. Neuro Oncol. 2024. PMID: 38141254

2

Grade II astrocytomas are subgrouped by chromosome aberrations.

Hirose Y, Aldape KD, Chang S, Lamborn K, Berger MS, Feuerstein BG. Hirose Y, et al. Cancer Genet Cytogenet. 2003 Apr 1;142(1):1-7. doi: 10.1016/s0165-4608(02)00791-4. Cancer Genet Cytogenet. 2003. PMID: 12660025

3

Gliomatosis cerebri: a review of 22 cases.

Vates GE, Chang S, Lamborn KR, Prados M, Berger MS. Vates GE, et al. Neurosurgery. 2003 Aug;53(2):261-71; discussion 271. doi: 10.1227/01.neu.0000073527.20655.e6. Neurosurgery. 2003. PMID: 12925240 Review.

4

Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.

Weber F, Asher A, Bucholz R, Berger M, Prados M, Chang S, Bruce J, Hall W, Rainov NG, Westphal M, Warnick RE, Rand RW, Floeth F, Rommel F, Pan H, Hingorani VN, Puri RK. Weber F, et al. J Neurooncol. 2003 Aug-Sep;64(1-2):125-37. doi: 10.1007/BF02700027. J Neurooncol. 2003. PMID: 12952293 Clinical Trial.

5

3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.

Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ. Pirzkall A, et al. Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):126-37. doi: 10.1016/j.ijrobp.2003.08.023. Int J Radiat Oncol Biol Phys. 2004. PMID: 15093908

6

Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging.

Cha S, Tihan T, Crawford F, Fischbein NJ, Chang S, Bollen A, Nelson SJ, Prados M, Berger MS, Dillon WP. Cha S, et al. AJNR Am J Neuroradiol. 2005 Feb;26(2):266-73. AJNR Am J Neuroradiol. 2005. PMID: 15709123 Free PMC article.

7

High failure rate in spinal ependymomas with long-term follow-up.

Gomez DR, Missett BT, Wara WM, Lamborn KR, Prados MD, Chang S, Berger MS, Haas-Kogan DA. Gomez DR, et al. Neuro Oncol. 2005 Jul;7(3):254-9. doi: 10.1215/S1152851704001231. Neuro Oncol. 2005. PMID: 16053700 Free PMC article.

8

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.

Prados MD, Lamborn K, Yung WK, Jaeckle K, Robins HI, Mehta M, Fine HA, Wen PY, Cloughesy T, Chang S, Nicholas MK, Schiff D, Greenberg H, Junck L, Fink K, Hess K, Kuhn J; North American Brain Tumor Consortium. Prados MD, et al. Neuro Oncol. 2006 Apr;8(2):189-93. doi: 10.1215/15228517-2005-010. Epub 2006 Mar 13. Neuro Oncol. 2006. PMID: 16533878 Free PMC article. Clinical Trial.

9

Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.

Li Y, Osorio JA, Ozturk-Isik E, Chen AP, Xu D, Crane JC, Cha S, Chang S, Berger MS, Vigneron DB, Nelson SJ. Li Y, et al. Magn Reson Imaging. 2006 Dec;24(10):1295-302. doi: 10.1016/j.mri.2006.07.012. Epub 2006 Oct 18. Magn Reson Imaging. 2006. PMID: 17145400

10

Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas.

McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP, Bollen A, Nelson SJ. McKnight TR, et al. J Neurosurg. 2007 Apr;106(4):660-6. doi: 10.3171/jns.2007.106.4.660. J Neurosurg. 2007. PMID: 17432719 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,067 results

Search Page